A Randomized Controlled Trial Investigating Tailored Treatment With Infliximab for Active Luminal Crohn's Disease.
Phase of Trial: Phase IV
Latest Information Update: 13 Aug 2015
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms TAILORIX
- 10 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record
- 14 Oct 2014 Last checked against European Clinical Trials Database record.
- 16 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.